Stryker hip lawsuits claim faulty hip implants caused severe pain and other complications that required surgery to repair. Over 3,400 people sued Stryker after problems with its Rejuvenate and ABG II hip implants led to recalls. Stryker Corporation is a major manufacturer of medical devices including hip implant systems. They published a release about “higher than expected complaints” of lock failures on their LFIT V40 but also Rejuvenate and ABG II hip components. Stryker settled lawsuits over the devices for $2 billion. But now, the company faces new lawsuits over its LFIT V40 but also Rejuvenate and ABG II hip components.
Below is a list of potential complications:
- Dislocation
- Pain associated with implant loosening
- Peri-prosthetic fracture
- Revision to alleviate hazardous situation
- Leg length discrepancy
- Loss of mobility secondary to hip/stem trunnion fracture or femoral head/hip stem dissociation
- Pain requiring revision surgery
- Inflammatory response
- Adverse local tissue reaction (ALTR)
Pending Lawsuits Against Stryker
Rejuvenate and AGB II Hip Implants
- Number of Lawsuits:1,240 lawsuits pending in Minnesota federal court (MDL-2441) as of May 2018.
- Settlements: $1.43 billion to settle thousands of lawsuits in 2014; expanded in 2016 to over $2 billion.
- Patient Injuries: High levels of metal ions in blood and urine; bone and tissue damage; severe pain and revision surgery
FIT V40 Femoral Head Products
- Number of Lawsuits: 2271 lawsuits pending in Massachusetts federal court (MDL-2768) as of May 2018; lawsuits filed in New Jersey are consolidated as multicounty litigation (MCL).
- Patient Injuries: Excessive wear and metallic debris; bone and tissue damage; severe pain; revision surgery and device failure, including disassociation of femoral head from hip stem and fractured hip stem trunnion.
